Trial Letdown Hits Possis Medical Shares of device maker Possis Medical (Nasdaq: POSS) are down 38 to \$19.20 after the company cut its fiscal 2005 earnings outlook after a trial involving its AngioJet blood clot treatment yielded disappointing results. 

Which of the following sections of a newspaper would this article likely appear in? World News, Sports, Business, or Science and Technology? 